The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
暂无分享，去创建一个
D. Pérol | L. Eberst | S. Chabaud | J. Delord | C. Ménétrier-Caux | C. Gomez-Roca | Aurélien Voissière | N. Bendriss-Vermare | G. Garin | Justine Berthet | A. Bidaux | I. Korakis | L. Montané | C. Rodriguez | Axelle Nkodia | Bertrand Dubois | Isabelle Treilleux | Christophe Caux | P. Cassier | C. Terret